What are Inactivated combination vaccine drugs?

Inactivated combination vaccine drugs are pharmacologic agents that share a common mechanism. 1 are currently marketed, with 5 more in clinical development.

What are the marketed Inactivated combination vaccine drugs?

Marketed Inactivated combination vaccine drugs include Infanrix TM.

Inactivated combination vaccine

1 marketed 5 in Phase 3

This page covers all Inactivated combination vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

Infanrix TM · GlaxoSmithKline · Immunology
Infanrix is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens.

Phase 3 pipeline (5)

RepevaxTM · GlaxoSmithKline · Immunology / Infectious Disease
Repevax is a booster vaccine that provides protection against diphtheria, tetanus, pertussis, and poliomyelitis through immunization with inactivated antigens.
REPEVAX™ (Concomitant) · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
REPEVAX is a booster vaccine that provides protection against diphtheria, tetanus, pertussis, and poliomyelitis by stimulating immune memory responses.
GSK Biologicals' DTPa-IPV/Hib vaccine · GlaxoSmithKline · Immunology / Infectious Disease Prevention
This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.
Comparator: Tripedia · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
Tripedia is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens.
REVAXIS® · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease
REVAXIS is a combined vaccine that provides active immunization against diphtheria, tetanus, and poliomyelitis by stimulating the immune system to produce antibodies against these three pathogens.